1. Home
  2. BDSX vs SNCR Comparison

BDSX vs SNCR Comparison

Compare BDSX & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.90

Market Cap

62.5M

Sector

Health Care

ML Signal

HOLD

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.69

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
SNCR
Founded
2005
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
59.5M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
BDSX
SNCR
Price
$7.90
$8.69
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
4.0M
160.6K
Earning Date
03-02-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,173,000.00
$170,909,000.00
Revenue This Year
$22.01
N/A
Revenue Next Year
$26.81
$4.37
P/E Ratio
N/A
N/A
Revenue Growth
22.29
0.07
52 Week Low
$3.44
$3.98
52 Week High
$23.56
$12.85

Technical Indicators

Market Signals
Indicator
BDSX
SNCR
Relative Strength Index (RSI) 53.75 75.49
Support Level $5.26 $8.49
Resistance Level $10.00 $8.73
Average True Range (ATR) 0.99 0.11
MACD 0.25 -0.10
Stochastic Oscillator 54.26 88.36

Price Performance

Historical Comparison
BDSX
SNCR

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: